AMA Demands FDA Scientific Standards for Marijuana Rescheduling
The headline says the AMA is demanding FDA scientific standards for marijuana rescheduling, but provides no details about the demand or any official rescheduling decision.
Related stories
US Tribunal Bars Papaya From Transferring Assets Abroad
A US tribunal barred Papaya from transferring assets abroad in litigation involving a Firy subsidiary.
M impact | REGULATION | Nov 02, 2026, 07:24 PM UTC
US Court Restricts Papaya Asset Transfers in Dispute With Skillz Subsidiary
A US court restricted Papaya asset transfers in a dispute involving Skillz subsidiary Firy, according to the headline.
M impact | REGULATION | Nov 02, 2026, 07:24 PM UTC
U.S. Bankruptcy Court Orders Papaya to Stop Moving Assets Outside the United States
M impact | REGULATION | Nov 02, 2026, 07:24 PM UTC
US Judge Dismisses Trump Administration’s Harvard Admissions Probe Case
A US judge dismissed the Trump administration’s case concerning its probe of Harvard admissions.
M impact | REGULATION | Nov 02, 2026, 07:12 PM UTC
Judge Dismisses Case Against Former FBI Officials
A judge dismissed the case against former FBI officials and said the Justice Department rushed the charges before the midterms.
L impact | REGULATION | Nov 02, 2026, 05:38 PM UTC
China launches measures to support struggling capital markets
M impact | REGULATION | Nov 02, 2026, 05:26 PM UTC